All In Biotech

Drug Trial Radar · NCT07684820

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

A Randomized, Double-Blind, Placebo-controlled, Parallel Arm, 52-week Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of Two Doses of EXPD-101 in Participants With COPD

Last checked: Nov 19, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 600 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

600

Planned (sponsor's estimate)

Start

Jun 30, 2026

Primary completion

Jun 30, 2028

Study completion Jul 11, 2028

Sponsor

Lead sponsor
Expedition Therapeutics, IncIndustry
Sponsor type
Industry
First posted
Jul 6, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 2 study of the efficacy, safety, tolerability and pharmacokinetics of two doses of EXPD-101 in participants with COPD. Study participants will be randomized to receive either study drug or placebo administered once daily for 52 weeks.

Conditions

  • Chronic Obstructive Pulmonary Disease (COPD)

Interventions

  • EXPD-101/FXS7553 Dose 1Drug

    Oral tablet

  • EXPD-101/FXS7553 Dose 2Drug

    Oral tablet

  • PlaceboDrug

    EXPD-101/FXS7553 - matching oral tablet.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Annualized rate of moderate and severe COPD exacerbationsTime frame: Over 52 Weeks
  2. The number of participants experiencing an adverse events (AEs)Time frame: Over 52 weeks
  3. Changes in vital sign parametersTime frame: Over 52 weeks
  4. Changes in electrocardiogram (ECG) parametersTime frame: Over 52 weeks
  5. Number of Participants with Clinically Significant Changes in Physical Examination FindingsTime frame: Over 52 weeks
  6. Number of participants with clinically significant abnormalitiesTime frame: Over 52 weeks
  7. Changes in Physical Exam Parameters - Body WeightTime frame: Over 52 weeks

Locations

35 sites in 4 countries. Site status is shown where the registry gives one.

  • DM Clinical Research - Phoenix

    Phoenix, Arizona · Recruiting

  • Leading Edge Research, LLC

    Encino, California · Recruiting

  • California Medical Research Associates Inc.

    Northridge, California · Recruiting

  • Lynn Institute of Denver

    Aurora, Colorado · Recruiting

  • International Clinical Research

    Altamonte Springs, Florida · Recruiting

  • Synergy Healthcare, LLC

    Bradenton, Florida · Recruiting

  • K2 Medical Research Winter Garden LLC

    Clermont, Florida · Recruiting

  • Nature Coast Clinical Research

    Crystal River, Florida · Recruiting

  • Clinical Site Partners, LLC Leesburg dba Flourish Research

    Leesburg, Florida · Recruiting

  • Suncoast Research Group, LLC Miami - Little Havana dba Flourish Research

    Miami, Florida · Recruiting

  • Optimal Research Sites

    Orange City, Florida · Recruiting

  • Centricity Research Rincon Pulmonology

    Rincon, Georgia · Recruiting

  • DM Clinical Research-Indianapolis

    Indianapolis, Indiana · Recruiting

  • University of Kansas Medical Center Research Institute, Inc.

    Kansas City, Kansas · Recruiting

  • Cotton O'Neil Clinical Research Center

    Topeka, Kansas · Recruiting

  • Care Access Research - Shreveport

    Shreveport, Louisiana · Recruiting

  • Headlands Research Twin Cities

    Maplewood, Minnesota · Recruiting

  • Hannibal Regional Healthcare System, Inc.

    Hannibal, Missouri · Recruiting

  • Eximia Research

    Raleigh, North Carolina · Recruiting

  • Carolina Research Center, Inc.

    Shelby, North Carolina · Recruiting

  • Remington-Davis Research

    Columbus, Ohio · Recruiting

  • Clinical Research Associates of Central PA, LLC

    DuBois, Pennsylvania · Recruiting

  • DM Clinical Research - Philadelphia

    Philadelphia, Pennsylvania · Recruiting

  • Clinical Research of Rock Hill

    Rock Hill, South Carolina · Recruiting

  • Horizon Clinical Research Group.

    Cypress, Texas · Recruiting

  • Metroplex Pulmonary and Sleep Center

    McKinney, Texas · Recruiting

  • DM Clinical Research - Tomball

    Tomball, Texas · Recruiting

  • Burke Internal Medicine, Inc.

    Burke, Virginia · Recruiting

  • Tidewater Clinical Research

    Virginia Beach, Virginia · Recruiting

  • Dynamic Drug Advancement

    Ajax, Ontario, Canada · Recruiting

  • Recherche GCP Research

    Montreal, Quebec, Canada · Recruiting

  • Recherche Clinique Sigma Inc.

    Québec, Quebec, Canada · Recruiting

  • Clinique de pneumologie et du sommeil de Lanaudière

    Saint-Charles-Borromée, Quebec, Canada · Recruiting

  • ARENSIA Exploratory Medicine, LLC

    Tbilisi, Georgia · Recruiting

  • ARENSIA Exploratory Medicine at Republican Clinical Hospital

    Chisinau, Moldova · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.